<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated the effects of recombinant human granulocyte colony stimulating factor (rhG-CSF) and granulocyte-monocyte colony stimulating factor (rhGM-CSF) on the in vitro proliferative, differentiative, and regenerative responsiveness of marrow cells from <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> patients (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) in comparison to those from <z:mpath ids='MPATH_458'>normal</z:mpath> individuals </plain></SENT>
<SENT sid="1" pm="."><plain>Our studies showed decreased primary clonogenicity of myeloid (CFU-GM) and erythroid (BFU-E) hemopoietic progenitor cells from the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>rhGM-CSF had more potent stimulatory effects than rhG-CSF for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow CFU-GM growth; no enhanced cellular proliferation in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients was observed in liquid culture with either rhGM-CSF or rhG-CSF </plain></SENT>
<SENT sid="3" pm="."><plain>Decreased myeloid clonal cell self-generation and/or recruitment occurred in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients upon exposure to either rhG-CSF or rhGM-CSF </plain></SENT>
<SENT sid="4" pm="."><plain>rhG-CSF demonstrated more potent granulocytic differentiation effects than rhGM-CSF both for <z:mpath ids='MPATH_458'>normals</z:mpath> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients using marrow enriched for immature myeloid cells with lesser differentiation noted for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Cytogenetic abnormalities, present with or without additional <z:mpath ids='MPATH_458'>normal</z:mpath> karyotypes in native marrow of four <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, persisted after culture with rhG-CSF, indicating induced differentiation of both <z:mpath ids='MPATH_458'>normal</z:mpath> and abnormal clones </plain></SENT>
<SENT sid="6" pm="."><plain>Although proliferative and differentiative effects were seen with both factors these data show <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow cells in vitro to have predominantly differentiative responsiveness to rhG-CSF and proliferative responsiveness to rhGM-CSF </plain></SENT>
</text></document>